aclidinium vs albuterol/ipratropium
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of aclidinium and albuterol/ipratropium. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Tudorza Pressair
Combivent Respimat, DuoNeb
No summary available.
Combivent Respimat is a combination medicine that helps open your airways. It contains two medicines: ipratropium and albuterol.
Information not available.
This medicine treats Chronic Obstructive Pulmonary Disease (COPD). It is for people who use a regular inhaler but still have trouble breathing. Combivent Respimat helps to reduce bronchospasm, which is the tightening of your airways.
Information not available.
Combivent Respimat contains two medicines that work in different ways. Albuterol relaxes the muscles in your airways, opening them up. Ipratropium helps to prevent the muscles around your airways from tightening.
- • Upper respiratory infection
- • Headache
- • Back pain
- • Upper respiratory infection
- • Runny nose and sore throat
- • Cough
- • Bronchitis
- • Headache
- Difficulty breathing 1,869
- Inhaler not working correctly 1,281
- Skipped a dose of medicine 1,017
- Asthma 814
- Chronic obstructive pulmonary disease (COPD) 764
- Difficulty breathing 15,966
- Asthma 9,278
- Cough 7,340
- Pneumonia 6,990
- Nausea 6,757
No specific warnings noted.
Combivent Respimat can cause your breathing to get worse (paradoxical bronchospasm). If this happens, stop using it right away and get medical help. This medicine can also cause heart problems, eye problems, and trouble urinating. Tell your doctor if you have any of these conditions.
No pregnancy information available.
Talk to your doctor if you are pregnant or breastfeeding before using this medicine. It is not known if Combivent Respimat will harm your unborn baby. It is also not known if this medicine passes into breast milk.
Also Compare, Nearby Drugs
Compare aclidinium with
How to Read This aclidinium vs albuterol/ipratropium Comparison
aclidinium is classified in the Long-Acting Muscarinic Antagonist (LAMA) drug class, while albuterol/ipratropium sits within the Beta-2 Agonist / Anticholinergic Combination class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, aclidinium has 5,745 submissions while albuterol/ipratropium has 46,331. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for aclidinium or albuterol/ipratropium.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.